Inventor · disambiguated record
Terry Hermiston
Also filed as: HERMISTON TERRY
30 granted patents·20 pending applications·375 citations·filing 1999–2023
96Inventor score
Files withBAYER HEALTHCARE LLC11ONYX PHARMA INC9COAGULANT THERAPEUTICS CORP5GLADIATOR BIOSCIENCES INC4HARDEN PAUL3
Top patents by PatentIndex Score
50 records- 0195US7550296B2Generation of replication competent viruses for therapeutic useBAYER SCHERING PHARMA AG·Filed 2005·Granted Jun 23, 2009·105 cites·58 claims
- 0295US6723316B2Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growthONYX PHARMA INC·Filed 2000·Granted Apr 20, 2004·71 cites·10 claims
- 0393US7510868B2Chimeric adenoviruses for use in cancer treatmentHARDEN PAUL·Filed 2005·Granted Mar 31, 2009·38 cites·6 claims
- 0492US7001596B1Oncolytic adenovirusONYX PHARMA INC·Filed 2000·Granted Feb 21, 2006·45 cites·11 claims
- 0591US8216819B2Generation of oncolytic adenoviruses and uses thereofHERMISTON TERRY·Filed 2007·Granted Jul 10, 2012·25 cites·12 claims
- 0690US8765463B2Chimeric adenoviruses for use in cancer treatmentHARDEN PAUL·Filed 2012·Granted Jul 1, 2014·14 cites·34 claims
- 0788US10894075B2Gla domains as targeting agentsGLADIATOR BIOSCIENCES INC·Filed 2014·Granted Jan 19, 2021·5 cites·14 claims
- 0887US10925926B2GLA domains as therapeutic agentsGLADIATOR BIOSCIENCES INC·Filed 2018·Granted Feb 23, 2021·2 cites·13 claims
- 0985US9694048B2Gla domains as targeting agentsBAYER HEALTHCARE LLC·Filed 2014·Granted Jul 4, 2017·6 cites·6 claims
- 1084US8158599B2Chimeric adenoviruses for use in cancer treatmentHARDEN PAUL·Filed 2009·Granted Apr 17, 2012·5 cites·8 claims
- 1183US6635244B2Adenovirus E1B-55K single amino acid mutants and methods of useONYX PHARMA INC·Filed 2001·Granted Oct 21, 2003·11 cites·7 claims
- 1281US7396679B2Oncolytic adenovirusONYX PHARMA INC·Filed 2002·Granted Jul 8, 2008·9 cites·16 claims
- 1381US7078030B2Oncolytic adenovirusONYX PHARMA INC·Filed 2003·Granted Jul 18, 2006·21 cites·9 claims
- 1477US2023295596A1Short-acting factor vii polypeptidesCOAGULANT THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1576US10717970B2Short-acting factor VII polypeptidesCOAGULANT THERAPEUTICS CORP·Filed 2016·Granted Jul 21, 2020·1 cites·18 claims
- 1675US9593166B2Monoclonal antibodies against antithrombin βBAYER HEALTHCARE LLC·Filed 2014·Granted Mar 14, 2017·2 cites·1 claims
- 1773US9115337B2Chimeric adenoviruses for use in cancer treatmentPSIOXUS THERAPEUTICS LTD·Filed 2013·Granted Aug 25, 2015·1 cites·4 claims
- 1870US11530401B2Short-acting Factor VII polypeptidesCOAGULANT THERAPEUTICS CORP·Filed 2020·Granted Dec 20, 2022·0 cites·22 claims
- 1970US9908942B2Monoclonal antibodies against antithrombin βBAYER HEALTHCARE LLC·Filed 2014·Granted Mar 6, 2018·1 cites·7 claims
- 2070US2021015900A1Gla domains as therapeutic agentsGLADIATOR BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2168US7785887B2Adenovirus E1B-55K single amino acid mutants and methods of useONYX PHARMA INC·Filed 2003·Granted Aug 31, 2010·1 cites·15 claims
- 2264US10273466B2Short-acting factor VII polypeptidesBAYER HEALTHCARE LLC·Filed 2014·Granted Apr 30, 2019·0 cites·14 claims
- 2364US9234185B2Chimeric adenoviruses for use in cancer treatmentPSIOXUS THERAPEUTICS LTD·Filed 2014·Granted Jan 12, 2016·0 cites·9 claims
- 2462US9034344B2Chimeric adenoviruses for use in cancer treatmentPSIOXUS THERAPEUTICS LTD·Filed 2013·Granted May 19, 2015·0 cites·5 claims
- 2562US8574594B2Generation of replication competent viruses for therapeutic useHERMISTON TERRY·Filed 2009·Granted Nov 5, 2013·0 cites·15 claims
- 2662US6660259B2Herpes simplex virus for treating unwanted hyperproliferative cell growthONYX PHARMA INC·Filed 2000·Granted Dec 9, 2003·1 cites·15 claims
- 2761US2006292122A1Adenoviral vectors for treating diseasesONYX PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 2861US2006257370A1Adenoviral vectors for treating diseasesONYX PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 2961US2006257371A1Adenoviral vectors for treating diseasesONYX PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 3060US2015344863A1Short-acting factor vii polypeptidesBAYER HEALTHCARE LLC·Filed 2013·Application pending·0 cites
- 3160US2025163183A1Camelid antibodies against activated protein c and uses thereofCOAGULANT THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 3260US2017296624A1Gla domains as targeting agentsBAYER HEALTHCARE LLC·Filed 2017·Application pending·0 cites
- 3357US10144784B2Monoclonal antibodies against antithrombin betaBAYER HEALTHCARE LLC·Filed 2018·Granted Dec 4, 2018·0 cites·18 claims
- 3457US8882484B2Methods and compositions for production of recombinant protein in HBX-expressing mammalian cellsJIN FANG·Filed 2009·Granted Nov 11, 2014·0 cites·13 claims
- 3557US2025188189A1Human antibodies against activated protein c and uses thereofCOAGULANT THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 3657US2015044768A1Methods and compositions for production of recombinant protein in hbx-expressing mammalian cellsBAYER HEALTHCARE LLC·Filed 2014·Application pending·0 cites
- 3755US7829329B2Adenoviral vectors for treating diseaseONYX PHARMA INC·Filed 2002·Granted Nov 9, 2010·0 cites·8 claims
- 3855US6764674B1Adenovirus E1B shuttle vectorsONYX PHARMA INC·Filed 1999·Granted Jul 20, 2004·11 cites·14 claims
- 3949US2011020925A1New modulating molecules for an improved regulated expression systemBAYER SCHERING PHARMA AG·Filed 2008·Application pending·0 cites
- 4046US9958459B2Application of N-terminomics to NETosis in inflammationBAYER HEALTHCARE LLC·Filed 2014·Granted May 1, 2018·0 cites·11 claims
- 4146US2016009817A1Pro-drug antibodies against tissue factor pathway inhibitorBAYER HEALTHCARE LLC·Filed 2014·Application pending·0 cites
- 4245US2003021768A1Viral mutants that selectively replicate in targeted human cancer cellsFiled 2002·Application pending·0 cites
- 4345US2007179113A1GM-CSF gene therapy for Crohn's disease using an improved regulated expression systemSCHERING AKTIENGESELLACHAFT·Filed 2007·Application pending·0 cites
- 4444US11981723B2Method of targeting exosomesGLADIATOR BIOSCIENCES INC·Filed 2018·Granted May 14, 2024·0 cites·26 claims
- 4542US2008076729A1Interferon-beta gene therapy using an improved, regulated expression systemSCHERING AKTIENGESELLACHAFT·Filed 2007·Application pending·0 cites
- 4641US2006281703A1Treatment of disease using an improved regulated expression systemSCHERING AG·Filed 2006·Application pending·0 cites
- 4741US2006292609A1Interferon-beta gene therapy using an improved, regulated expression systemSCHERING AG·Filed 2006·Application pending·0 cites
- 4840US2012178693A1Cofactors for Thrombin Activation of Factor VII and Uses ThereofLIGHT DAVID·Filed 2010·Application pending·0 cites
- 4935US2017218035A1Compositions and methods for treatment with hemopexinBAYER HEALTHCARE LLC·Filed 2015·Application pending·0 cites
- 5023US2002037274A1Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutantsFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Terry Hermiston files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →